PUI
QNTM

Purpose Unlimited Inc’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Purpose Unlimited Inc’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4 Hold
1
– – ﹤0.01% 574
2025
Q4 		$7 Buy
+1
New +$11 ﹤0.01% 400

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
PTP
Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Purpose Unlimited Inc's QNTM Position: Q1 2026 in Review

Purpose Unlimited Inc held its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) position steady in Q1 2026 at 1 share worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #574.

Purpose Unlimited Inc first reported a position in QNTM in Q4 2025 and has held it in 2 quarters since. The position peaked at $7 in Q4 2025. 25 funds tracked by Wall St. Rank hold QNTM as of Q1 2026.

  • Purpose Unlimited Inc held 1 share of Quantum Biopharma Class B Subordinate Voting Shares worth $4 as of Q1 2026.
  • Purpose Unlimited Inc left its Quantum Biopharma Class B Subordinate Voting Shares share count unchanged in Q1 2026.
  • Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Purpose Unlimited Inc's portfolio in Q1 2026, its #574 holding.
  • Purpose Unlimited Inc first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q4 2025 and has held it in 2 quarters since.
  • Purpose Unlimited Inc's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $7 in Q4 2025.
  • 25 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2026.

Based on Purpose Unlimited Inc's 13F filing for Q1 2026, filed 15 May 2026.